Mpm Bioimpact
Asset Manager SEC-registered adviser
Legal name: Mpm Asset Management LLC
AUM
$3.6B
Regulatory AUM
Private funds
14
Venture Capital 8 · Other 3 · Hedge Fund 3
Private fund assets
$3.5B
Gross asset value
Employees
50
Last Form D raise
Jun 2026
Most recent fund filing
From SEC Form ADV filing (filed Apr 28, 2026). View on SEC
People(5)
Owners and executive officers named on the firm's SEC Form ADV.
A
C
L
P
T
Funds(14)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Mpm Bioimpact Innovations Equities Master, LP | Hedge Fund | $253.9M | $407K | 1 | Jun 2026 | Hot |
| Bioimpact Equities Fund, LP | Hedge Fund | $312.3M | $125.5M | 93 | Mar 2026 | Warm |
| Bioimpact Equities Master Fund, LP | Hedge Fund | $90.9M | $2.6M | 5 | Mar 2026 | Warm |
| Mpm Bioventures 2022, L.P. | Venture Capital | $350.7M | $351.0M | 45 | Jun 2023 | Cold |
| Oncology Impact Fund 2, L.P. | Other | $1.0B | $326.8M | 31 | Nov 2021 | Cold |
| Mpm Oncology Innovations Fund L.P. | Venture Capital | $130.9M | $98.9M | 36 | Feb 2020 | Cold |
| Mpm Asset Management Investors BV2018 LLC | Venture Capital | $10.5M | $7.5M | 25 | Nov 2018 | Cold |
| Mpm Bioventures 2018 (b), L.P. | Venture Capital | $24.8M | — | — | Feb 2018 | Cold |
| Mpm Bioventures 2018, L.P. | Venture Capital | $483.2M | — | — | Feb 2018 | Cold |
| Mpm Bioventures 2014, L.P. | Venture Capital | $72.4M | $347.3M | 94 | Jul 2015 | Cold |
| Ubs Oncology Impact Fund L.P. | Other | $570.5M | — | — | — | |
| New Technologies and Virology Fund, L.P. | Other | $140.2M | — | — | — | |
| Mpm Bioventures 2014 (b), L.P. | Venture Capital | $4.8M | — | — | — | |
| Mpm Asset Management Investors BV2014 LLC | Venture Capital | $4.0M | — | — | — |
Board seats(6)
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
Regulatory identifiers
- CRD number
- 148467
- SEC file number
- 801-106989
- CIK
- 1263048
Sources
- SEC Form ADV Oct 14, 2026